Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Current Opinion in Gastroenterology|January 9, 2025
Current approach to diagnosis and management of low-phospholipid associated cholelithiasis syndromePierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
La Revue Du Praticien|January 23, 2026
[Low phospholipidassociated cholelithiasis syndrome]Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Hepatology (Baltimore, Md.)|June 27, 2006
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosisRaoul Poupon, Olivier Chazouilleres, Christophe Corpechot, et al.
Journal of Hepatology|May 18, 2010
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosisChristophe Corpechot, Yves Chrétien, Olivier Chazouillères, et al.
Gastroenterology|March 5, 2002
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patientsChristophe Corpechot, Fabrice Carrat, Raoul Poupon, et al.
Hepatology (Baltimore, Md.)|August 21, 2015
Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsPalak J Trivedi, Christophe Corpechot, Albert Pares, et al.
Annales De Pathologie|July 20, 2015
[Cholangitis with granulocytic epithelial lesion: a new entity with a specific treatment]Jessica Calvo, Valérie Dhalluin-Venier, Lionel Arrivé, et al.
Clinics and Research in Hepatology and Gastroenterology|April 18, 2015
Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysisAlla Y Grigorian, Houssam E Mardini, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|July 17, 2013
Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progressionAna Ruiz, Sara Lemoinne, Fabrice Carrat, et al.
The American Journal of Gastroenterology|September 6, 2006
Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acidsChristophe Corpechot, Chen Ping, Dominique Wendum, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Current Opinion in Gastroenterology|January 9, 2025
Current approach to diagnosis and management of low-phospholipid associated cholelithiasis syndromePierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
La Revue Du Praticien|January 23, 2026
[Low phospholipidassociated cholelithiasis syndrome]Pierre-Antoine Soret, Olivier Chazouillères, Christophe Corpechot
Hepatology (Baltimore, Md.)|June 27, 2006
Development of autoimmune hepatitis in patients with typical primary biliary cirrhosisRaoul Poupon, Olivier Chazouilleres, Christophe Corpechot, et al.
Journal of Hepatology|May 18, 2010
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosisChristophe Corpechot, Yves Chrétien, Olivier Chazouillères, et al.
Gastroenterology|March 5, 2002
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patientsChristophe Corpechot, Fabrice Carrat, Raoul Poupon, et al.
Hepatology (Baltimore, Md.)|August 21, 2015
Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsPalak J Trivedi, Christophe Corpechot, Albert Pares, et al.
Annales De Pathologie|July 20, 2015
[Cholangitis with granulocytic epithelial lesion: a new entity with a specific treatment]Jessica Calvo, Valérie Dhalluin-Venier, Lionel Arrivé, et al.
Clinics and Research in Hepatology and Gastroenterology|April 18, 2015
Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysisAlla Y Grigorian, Houssam E Mardini, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|July 17, 2013
Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progressionAna Ruiz, Sara Lemoinne, Fabrice Carrat, et al.
The American Journal of Gastroenterology|September 6, 2006
Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acidsChristophe Corpechot, Chen Ping, Dominique Wendum, et al.
Pageof 12